scispace - formally typeset
D

Debra A. Schmitz

Researcher at University of California, Los Angeles

Publications -  40
Citations -  5157

Debra A. Schmitz is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Metabolite & Particulates. The author has an hindex of 21, co-authored 40 publications receiving 4830 citations. Previous affiliations of Debra A. Schmitz include Oklahoma State University Center for Health Sciences.

Papers
More filters
Journal ArticleDOI

Redox activity of airborne particulate matter at different sites in the Los Angeles Basin.

TL;DR: It is found that PM will catalyze the reduction of oxygen and the distribution and chemical characteristics of the redox activity of PM fractions collected in different sites in the Los Angeles Basin are examined.
Journal ArticleDOI

Nrf2 Is a Key Transcription Factor That Regulates Antioxidant Defense in Macrophages and Epithelial Cells: Protecting against the Proinflammatory and Oxidizing Effects of Diesel Exhaust Chemicals

TL;DR: This study investigates the mechanism by which redox cycling organic chemicals, prepared from DEP, induce phase II enzyme expression as a protective response and proposes that Nrf2-mediated phase II enzymes expression protects against the proinflammatory effects of particulate pollutants in the setting of allergic inflammation and asthma.
Journal ArticleDOI

Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production

TL;DR: Investigating whether induction of nitric oxide synthase (NOS) by LPS and cytokines is accompanied by sufficient arginase induction to render arginine concentrations rate limiting for high-output NO production reveals for the first time that substantial arginases activity is present constitutively in rat aortic endothelial cells.
Journal ArticleDOI

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

TL;DR: In incubation of MDMA isomers with human liver microsomes indicated that their demethylenation is deficient in the poor metabolizer phenotype, and this may give rise to genetically-determined differences in toxicity.